Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
20%(1 trials)

Phase Distribution

Ph phase_4
2
22%
Ph phase_2
2
22%
Ph phase_3
2
22%
Ph not_applicable
3
33%

Phase Distribution

0

Early Stage

2

Mid Stage

4

Late Stage

Phase Distribution9 total trials
Phase 2Efficacy & side effects
2(22.2%)
Phase 3Large-scale testing
2(22.2%)
Phase 4Post-market surveillance
2(22.2%)
N/ANon-phased studies
3(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

9

all time

Status Distribution
Active(1)
Completed(5)
Other(3)

Detailed Status

Completed5
unknown3
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (22.2%)
Phase 32 (22.2%)
Phase 42 (22.2%)
N/A3 (33.3%)

Trials by Status

unknown333%
not_yet_recruiting111%
completed556%

Recent Activity

0 active trials
Showing 5 of 9
completedphase_3

Prophylaxis of Post-ERCP Acute Pancreatitis

NCT05381428
not_yet_recruitingphase_2

Efficacy and Safety of Parecoxib vs. Indomethacin in Preventing Post-ERCP Pancreatitis

NCT06623513
completednot_applicable

The Optimal Dose of Indomethacin Suppository for Preventing Post-ERCP Pancreatitis

NCT06031363
unknownphase_2

Efficacy of Rectal Indomethacin in Prevention of Post-pancreatectomy Acute Pancreatitis

NCT05722548
completednot_applicable

Efficacy of Rectal Indomethacin in Prevention of Post-operative Pancreatitis After Pancreaticoduodenectomy

NCT05109143
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT05381428Phase 3

Prophylaxis of Post-ERCP Acute Pancreatitis

Completed
NCT06623513Phase 2

Efficacy and Safety of Parecoxib vs. Indomethacin in Preventing Post-ERCP Pancreatitis

Not Yet Recruiting
NCT06031363Not Applicable

The Optimal Dose of Indomethacin Suppository for Preventing Post-ERCP Pancreatitis

Completed
NCT05722548Phase 2

Efficacy of Rectal Indomethacin in Prevention of Post-pancreatectomy Acute Pancreatitis

Unknown
NCT05109143Not Applicable

Efficacy of Rectal Indomethacin in Prevention of Post-operative Pancreatitis After Pancreaticoduodenectomy

Completed
NCT02797067Phase 4

Rectal Indomethacin to Prevent Post ESWL-pancreatitis

Completed
NCT04964180Not Applicable

Rectal Indomethacin Versus Intraperitoneal Lidocaine for Analgesia After Laparoscopic Cholecystectomy

Completed
NCT03708458Phase 4

Pharmacological Prophylaxis of Post- Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis

Unknown
NCT01742689Phase 3

Analgesic Efficacy of Intranasal Desmopressin in Acute Renal Colic

Unknown

All 9 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
9